Fulcrum Therapeutics, Inc. (FULC) Financials

FULC Assets vs Liabilities
DateAssetsLiabilities
March 31, 2026 346.8 million 13.5 million
Dec. 31, 2025 366.3 million 17.3 million
Sept. 30, 2025 214.9 million 16.5 million
June 30, 2025 228.8 million 14.5 million

FULC Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2026 -18.8 million 3.9 million
Dec. 31, 2025 -17.0 million 3.1 million
Sept. 30, 2025 -14.3 million 3.4 million
June 30, 2025 -13.9 million 2.9 million

FULC Net Income

No data available :(

FULC Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 333.3 million 3.4 million 5.9 million
Dec. 31, 2025 352.3 million 4.0 million 6.4 million
Sept. 30, 2025 200.6 million - 7.0 million
June 30, 2025 214.1 million - 7.6 million

FULC Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2026 76.2 million
Dec. 31, 2025 63.4 million
Sept. 30, 2025 62.6 million
June 30, 2025 62.5 million

FULC Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 8000 14.1 million 8.1 million -
Dec. 31, 2025 159000 15.4 million 7.3 million -
Sept. 30, 2025 90000 14.3 million 7.6 million -
June 30, 2025 65000 13.0 million 6.8 million -

FULC Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 - 338000
Dec. 31, 2025 - -300000
Sept. 30, 2025 - -
June 30, 2025 - 300000

FULC

Price: $3.46

52 week price:
2.83
15.74

Earnings Per Share: -1.15 USD

Exchange: NGM

Sector: Healthcare

Industry: Biotechnology

Country: United States

Volume: 493900

Market Capitalization: 199.7 million

Links: